Cytokine induced killer cell(ltalian Sarcoma Group)

N/A

Report date: 2023/03/15 10:34:34

Base Information

Drug NameCytokine induced killer cell(ltalian Sarcoma Group)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cell
Mechanisms of ActionImmunostimulantsCytokine-induced killer cells stimulants
TargetsNot applicable
Therapy Area/IndicationsSarcoma, Experimental
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesItalian Sarcoma Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesItalian Sarcoma Group
Active IndicationsN/A
Inactive IndicationsSarcoma, Experimental

Other Information

ATC CodeN/A
Related LinksN/A